Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gabriela M. Asencio Torres"'
Autor:
Gabriela M. Asencio Torres, Helen Piwnica-Worms, Cullen M. Taniguchi, Tara N. Fujimoto, Xiaomei Zhang, Jessica M. Molkentine, Kristina M. Stemler, Marimar de la Cruz Bonilla, Russell Broaddus, Sabrina Jeter-Jones
Publikováno v:
Int J Radiat Oncol Biol Phys
Purpose Chemotherapy combined with radiation therapy is the most commonly used approach for treating locally advanced pancreatic cancer. The use of curative doses of radiation in this disease setting is constrained because of the close proximity of t
Autor:
José R. Rodríguez-Medina, Brian C. Rymond, Julia Medina-Velázquez, Suranganie Dharmawardhane, Michael John Rivera-Robles, Gabriela M. Asencio-Torres, Sahily González-Crespo
Publikováno v:
The FASEB Journal. 32
Autor:
Suranganie Dharmawardhane, Cornelis P. Vlaar, Gabriela M. Asencio-Torres, Eliud Hernandez, Linette Castillo-Pichardo
Publikováno v:
The FASEB Journal. 32
Autor:
Suranganie Dharmawardhane, Sahily González-Crespo, Julia Medina-Velázquez, Brian C. Rymond, José R. Rodríguez-Medina, Gabriela M. Asencio-Torres, Michael John Rivera-Robles
Publikováno v:
Small GTPases
The Rho GTPase Cdc42 is highly conserved in structure and function. Mechanical or chemical cues in the microenvironment stimulate the localized activation of Cdc42 to rearrange the actin cytoskeleton and establish cell polarity. A role for Cdc42 in c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27472260f6e8fc4bf4dc61aa1b8efcf8
Autor:
Gabriela M. Asencio-Torres, Sahily González-Crespo, Suranganie Dharmawardhane, José R. Rodríguez-Medina, Michael John Rivera-Robles, Brian C. Rymond, Julia Medina-Velázquez
Publikováno v:
Cancer Research. 78:3994-3994
Cdc42 (cell division control protein 42 homolog) is a Rho GTPase highly conserved among eukaryotes in structure and function. Mechanical or chemical cues in the microenvironment stimulate the localized activation of Cdc42, aiding cells to polarize an
Autor:
Gabriela M. Asencio Torres, Jessica M. Molkentine, Sabrina Jeter-Jones, Kristina M. Stemler, Helen Piwnica-Worms, Cullen M. Taniguchi, Tara N. Fujimoto, Marimar de la Cruz Bonilla
Publikováno v:
Cancer Research. 78:4164-4164
Pancreatic cancer is the fourth leading cause of cancer-related deaths in the US. Surgical resection is the only potentially curative treatment; however, only 15%-20% of patients present with tumors that can be resected. There is no consensus regardi